Shandong Weifang Rainbow Chemical Co., Ltd (SHE:301035)
China · Delayed Price · Currency is CNY 84.75
-2.81 (-3.21%)
At close: Apr 30, 2026
SHE:301035 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 15,193 | 14,688 | 13,279 | 11,438 | 14,324 | 9,681 |
Other Revenue | - | - | 17.18 | 46.4 | 136.55 | 116.51 |
| 15,193 | 14,688 | 13,296 | 11,485 | 14,460 | 9,797 | |
Revenue Growth (YoY) | 14.33% | 10.47% | 15.77% | -20.58% | 47.60% | 34.39% |
Cost of Revenue | 11,602 | 11,339 | 10,705 | 9,070 | 11,541 | 7,954 |
Gross Profit | 3,591 | 3,349 | 2,591 | 2,415 | 2,920 | 1,843 |
Selling, General & Admin | 1,349 | 1,322 | 1,191 | 941.65 | 657.99 | 501.91 |
Research & Development | 188.25 | 183.34 | 169.42 | 298.48 | 335.09 | 312.44 |
Other Operating Expenses | 66.64 | 68.97 | 62.45 | 29.39 | 17.99 | 12.97 |
Operating Expenses | 1,604 | 1,574 | 1,584 | 1,341 | 1,067 | 862.82 |
Operating Income | 1,987 | 1,775 | 1,007 | 1,074 | 1,852 | 980.64 |
Interest Expense | - | - | -131.1 | -64.2 | -24.12 | -26.67 |
Interest & Investment Income | - | - | 108.5 | 44.86 | 54.42 | 255.16 |
Currency Exchange Gain (Loss) | - | - | -552.55 | 78.67 | 333.84 | -87.23 |
Other Non Operating Income (Expenses) | -377.19 | -122.11 | -42.72 | -19.91 | -17.2 | -27.62 |
EBT Excluding Unusual Items | 1,609 | 1,653 | 389.41 | 1,114 | 2,199 | 1,094 |
Impairment of Goodwill | - | - | -4.53 | - | - | - |
Gain (Loss) on Sale of Investments | -185.24 | -152.76 | 51.68 | -175.41 | -430.56 | -84.36 |
Gain (Loss) on Sale of Assets | -0.33 | -0.76 | 0.3 | -0.15 | -0.02 | -3.61 |
Asset Writedown | -41.84 | -40.03 | -16.44 | -8.44 | -27.96 | -32.16 |
Other Unusual Items | - | - | -7.46 | 10.53 | 12.08 | 15.23 |
Pretax Income | 1,382 | 1,460 | 412.96 | 940.38 | 1,753 | 989.39 |
Income Tax Expense | 287.24 | 282.48 | -115.43 | 90.27 | 265.08 | 143.34 |
Earnings From Continuing Operations | 1,095 | 1,177 | 528.39 | 850.11 | 1,488 | 846.05 |
Minority Interest in Earnings | -141.74 | -132.72 | -78.3 | -78.99 | -74.27 | -46.33 |
Net Income | 953.09 | 1,045 | 450.08 | 771.12 | 1,413 | 799.72 |
Net Income to Common | 953.09 | 1,045 | 450.08 | 771.12 | 1,413 | 799.72 |
Net Income Growth | 72.04% | 132.07% | -41.63% | -45.44% | 76.72% | 82.74% |
Shares Outstanding (Basic) | 278 | 279 | 280 | 277 | 276 | 236 |
Shares Outstanding (Diluted) | 280 | 280 | 280 | 278 | 279 | 236 |
Shares Change (YoY) | -0.38% | 0.17% | 0.42% | -0.13% | 18.16% | 13.74% |
EPS (Basic) | 3.43 | 3.75 | 1.61 | 2.78 | 5.12 | 3.39 |
EPS (Diluted) | 3.41 | 3.73 | 1.61 | 2.77 | 5.07 | 3.39 |
EPS Growth | 72.70% | 131.68% | -41.88% | -45.37% | 49.56% | 60.66% |
Free Cash Flow | 777.47 | 1,206 | -85.69 | -1,989 | 773.93 | 176.46 |
Free Cash Flow Per Share | 2.78 | 4.31 | -0.31 | -7.14 | 2.78 | 0.75 |
Dividend Per Share | - | - | 0.590 | 1.000 | 1.630 | 1.373 |
Dividend Growth | - | - | -41.00% | -38.65% | 18.72% | - |
Gross Margin | 23.64% | 22.80% | 19.49% | 21.03% | 20.19% | 18.82% |
Operating Margin | 13.08% | 12.09% | 7.58% | 9.35% | 12.81% | 10.01% |
Profit Margin | 6.27% | 7.11% | 3.38% | 6.71% | 9.77% | 8.16% |
Free Cash Flow Margin | 5.12% | 8.21% | -0.64% | -17.32% | 5.35% | 1.80% |
EBITDA | 2,341 | 2,118 | 1,307 | 1,326 | 2,031 | 1,120 |
EBITDA Margin | 15.40% | 14.42% | 9.83% | 11.54% | 14.05% | 11.43% |
D&A For EBITDA | 353.86 | 343.07 | 299.91 | 251.26 | 179.26 | 139.14 |
EBIT | 1,987 | 1,775 | 1,007 | 1,074 | 1,852 | 980.64 |
EBIT Margin | 13.08% | 12.09% | 7.58% | 9.35% | 12.81% | 10.01% |
Effective Tax Rate | 20.78% | 19.35% | - | 9.60% | 15.13% | 14.49% |
Revenue as Reported | - | - | 13,296 | 11,485 | 14,460 | 9,797 |
Advertising Expenses | - | - | 29.8 | 12.24 | 7.9 | 9.68 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.